316 related articles for article (PubMed ID: 18752762)
1. Application of cardiac magnetic resonance imaging in cardiomyopathy.
Steel KE; Kwong RY
Curr Heart Fail Rep; 2008 Sep; 5(3):128-35. PubMed ID: 18752762
[TBL] [Abstract][Full Text] [Related]
2. Do clinical diagnoses correlate with pathological diagnoses in cardiac transplant patients? The importance of endomyocardial biopsy.
Luk A; Metawee M; Ahn E; Gustafsson F; Ross H; Butany J
Can J Cardiol; 2009 Feb; 25(2):e48-54. PubMed ID: 19214301
[TBL] [Abstract][Full Text] [Related]
3. [Patterns of delayed-enhancement in MRI of ischemic and non-ischemic cardiomyopathies].
Stork A; Müllerleile K; Bansmann PM; Koops A; Meinertz T; Adam G; Lund GK
Rofo; 2007 Jan; 179(1):21-30. PubMed ID: 17203440
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular magnetic resonance assessment of ischemic and nonischemic cardiomyopathies.
Raney AR; Bello D
Heart Fail Clin; 2006 Apr; 2(2):145-61. PubMed ID: 17386886
[No Abstract] [Full Text] [Related]
5. Evolving diagnostic and prognostic imaging of the various cardiomyopathies.
Sanz J
Ann N Y Acad Sci; 2012 Apr; 1254():123-130. PubMed ID: 22548578
[TBL] [Abstract][Full Text] [Related]
6. Risk stratification for therapeutic management and prognosis.
Coelho-Filho OR; Nallamshetty L; Kwong RY
Heart Fail Clin; 2009 Jul; 5(3):437-55, vii. PubMed ID: 19564018
[TBL] [Abstract][Full Text] [Related]
7. Cardiac magnetic resonance imaging for stage B heart failure.
Partington SL; Cheng S; Lima JA
Heart Fail Clin; 2012 Apr; 8(2):179-90. PubMed ID: 22405659
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular magnetic resonance in the evaluation of hypertrophic and infiltrative cardiomyopathies.
O'Hanlon R; Pennell DJ
Heart Fail Clin; 2009 Jul; 5(3):369-87, vi. PubMed ID: 19564014
[TBL] [Abstract][Full Text] [Related]
9. The role of cardiovascular magnetic resonance in the diagnosis and management of cardiomyopathies.
Masci PG; Dymarkowski S; Bogaert J
J Cardiovasc Med (Hagerstown); 2008 May; 9(5):435-49. PubMed ID: 18403995
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging in patients with cardiomyopathies: when and why.
Schulz-Menger J; Friedrich MG
Herz; 2000 Jun; 25(4):384-91. PubMed ID: 10948774
[TBL] [Abstract][Full Text] [Related]
11. Role of cardiac magnetic resonance imaging in assessment of nonischemic cardiomyopathies.
Shehata ML; Turkbey EB; Vogel-Claussen J; Bluemke DA
Top Magn Reson Imaging; 2008 Feb; 19(1):43-57. PubMed ID: 18690160
[TBL] [Abstract][Full Text] [Related]
12. Contemporary Application of Cardiovascular Magnetic Resonance Imaging.
Han Y; Chen Y; Ferrari VA
Annu Rev Med; 2020 Jan; 71():221-234. PubMed ID: 31986088
[TBL] [Abstract][Full Text] [Related]
13. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology.
Maron BJ; Udelson JE; Bonow RO; Nishimura RA; Ackerman MJ; Estes NAM; Cooper LT; Link MS; Maron MS
J Am Coll Cardiol; 2015 Dec; 66(21):2362-2371. PubMed ID: 26542657
[No Abstract] [Full Text] [Related]
14. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology.
Maron BJ; Udelson JE; Bonow RO; Nishimura RA; Ackerman MJ; Estes NA; Cooper LT; Link MS; Maron MS;
Circulation; 2015 Dec; 132(22):e273-80. PubMed ID: 26621644
[No Abstract] [Full Text] [Related]
15. Magnetic resonance imaging of primary cardiomyopathies.
Soler R; Rodríguez E; Remuiñán C; Bello MJ; Díaz A
J Comput Assist Tomogr; 2003; 27(5):724-34. PubMed ID: 14501363
[TBL] [Abstract][Full Text] [Related]
16. Sudden death related cardiomyopathies - Arrhythmogenic right ventricular cardiomyopathy, arrhythmogenic cardiomyopathy, and exercise-induced cardiomyopathy.
Goff ZD; Calkins H
Prog Cardiovasc Dis; 2019; 62(3):217-226. PubMed ID: 31004608
[TBL] [Abstract][Full Text] [Related]
17. Utility of cardiac magnetic resonance imaging to differentiate cardiac sarcoidosis from arrhythmogenic right ventricular cardiomyopathy.
Steckman DA; Schneider PM; Schuller JL; Aleong RG; Nguyen DT; Sinagra G; Vitrella G; Brun F; Cova MA; Pagnan L; Mestroni L; Varosy PD; Sauer WH
Am J Cardiol; 2012 Aug; 110(4):575-9. PubMed ID: 22595349
[TBL] [Abstract][Full Text] [Related]
18. The emerging role of MRI in the diagnosis and management of cardiomyopathies.
Rochitte CE; Tassi EM; Shiozaki AA
Curr Cardiol Rep; 2006 Feb; 8(1):44-52. PubMed ID: 16507236
[TBL] [Abstract][Full Text] [Related]
19. Clinical application of cardiac CMR.
Al-Mallah M; Kwong RY
Rev Cardiovasc Med; 2009; 10(3):134-41. PubMed ID: 19898290
[TBL] [Abstract][Full Text] [Related]
20. Electrocardiogram and Imaging: An Integrated Approach to Arrhythmogenic Cardiomyopathies.
Savino K; Bagliani G; Crusco F; Padeletti M; Lombardi M
Card Electrophysiol Clin; 2018 Jun; 10(2):413-429. PubMed ID: 29784492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
